These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 15102547)
1. Role of pharmacoproteomics in the development of personalized medicine. Jain KK Pharmacogenomics; 2004 Apr; 5(3):331-6. PubMed ID: 15102547 [TBL] [Abstract][Full Text] [Related]
2. Role of Proteomics in the Development of Personalized Medicine. Jain KK Adv Protein Chem Struct Biol; 2016; 102():41-52. PubMed ID: 26827601 [TBL] [Abstract][Full Text] [Related]
5. Challenges of drug discovery for personalized medicine. Jain KK Curr Opin Mol Ther; 2006 Dec; 8(6):487-92. PubMed ID: 17243483 [TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomics: current applications and future prospects towards personalized therapeutics. Vaiopoulou A; Gazouli M; Karikas GA J BUON; 2013; 18(3):570-8. PubMed ID: 24065466 [TBL] [Abstract][Full Text] [Related]
7. Technology insight: pharmacoproteomics for cancer--promises of patient-tailored medicine using protein microarrays. Wulfkuhle JD; Edmiston KH; Liotta LA; Petricoin EF Nat Clin Pract Oncol; 2006 May; 3(5):256-68. PubMed ID: 16683004 [TBL] [Abstract][Full Text] [Related]
8. Pharmacoproteomics: a chess game on a protein field. D'Alessandro A; Zolla L Drug Discov Today; 2010 Dec; 15(23-24):1015-23. PubMed ID: 20969973 [TBL] [Abstract][Full Text] [Related]
13. Role of oncoproteomics in the personalized management of cancer. Jain KK Expert Rev Proteomics; 2004 Jun; 1(1):49-55. PubMed ID: 15966798 [TBL] [Abstract][Full Text] [Related]
14. From personalized medicine to personalized justice: the promises of translational pharmacogenomics in the justice system. Wong SH; Happy C; Blinka D; Gock S; Jentzen JM; Donald Hon J; Coleman H; Jortani SA; Lucire Y; Morris-Kukoski CL; Neuman MG; Orsulak PJ; Sander T; Wagner MA; Wynn JR; Wu AH; Yeo KT Pharmacogenomics; 2010 Jun; 11(6):731-7. PubMed ID: 20504247 [No Abstract] [Full Text] [Related]
15. [A new approach to pharmacogenomics]. Fujita Y Nihon Yakurigaku Zasshi; 2000 Sep; 116(3):149-57. PubMed ID: 11031744 [TBL] [Abstract][Full Text] [Related]
16. DxS Ltd. Little S Pharmacogenomics; 2003 Jan; 4(1):97-101. PubMed ID: 12517290 [TBL] [Abstract][Full Text] [Related]
17. [Pharmacogenomics and the path towards personalized medicine]. Belloso WH; Redal MA Medicina (B Aires); 2010; 70(3):265-74. PubMed ID: 20529779 [TBL] [Abstract][Full Text] [Related]
18. Pharmacogenomics: historical perspective and current status. Charlab R; Zhang L Methods Mol Biol; 2013; 1015():3-22. PubMed ID: 23824846 [TBL] [Abstract][Full Text] [Related]
19. Genomics and proteomics tools for compound mode-of-action studies in drug discovery. Kley N; Ivanov I; Meier-Ewert S Pharmacogenomics; 2004 Jun; 5(4):395-404. PubMed ID: 15165175 [TBL] [Abstract][Full Text] [Related]
20. Pharmacoproteomics: advancing the efficacy and safety of regenerative therapeutics. Arrell DK; Niederländer NJ; Perez-Terzic C; Chung S; Behfar A; Terzic A Clin Pharmacol Ther; 2007 Sep; 82(3):316-9. PubMed ID: 17671447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]